PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, UK.\', \'ImmunoServ Ltd, Cardiff, UK.\', \'School of Medicine, Systems Immunity University Research Institute, Cardiff University, Cardiff, UK.\', \'UK Dementia Research Institute Cardiff, Cardiff University, Cardiff, UK.\', \'Radyr Medical Centre, Cardiff, UK.\', \'Department of Gastroenterology & Hepatology, University Hospital of Wales, Cardiff, UK.\', \'Velindre Cancer Centre, Cardiff, UK.\', \'School of Life Sciences, University of Nottingham, Nottingham, UK.\', \'Department of Medicine, Addenbrooke\'s Hospital, University of Cambridge, Cambridge, UK.\', \'School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/imm.13433
?:doi
?:hasPublicationType
?:journal
  • Immunology
is ?:pmid of
?:pmid
?:pmid
  • 34775604
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.69
?:rankingScore_hIndex
  • 115
is ?:relation_isRelatedTo_publication of
?:title
  • Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all